The Power Of Microfluidics To Enhance Particle Performance Selectscience Nanoparticles News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The COVID-19 pandemic brought lipid nanoparticles (LNPs) to prominence, with multiple pharmaceutical manufacturers – including Moderna and Pfizer-BioNTech – rapidly developing mRNA-LNP vaccines that were administered globally. The success of these vaccines has firmly established the potential of this technology to help treat a broad scope of diseases and illnesses, especially using gene therapy approaches, where LNPs are already demonstrating promise as non-viral delivery vectors. How ....

United Kingdom , Alecd Bangham , Alis Automated Library Synthesis System , Editorial Article , Automated Library Synthesis , Automated Nanoparticle , Particle Works , The Power Of Microfluidics To Enhance Particle Performance Selectscience Nanoparticles , Particle Works , Np System , Lis System ,